INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Other Accounts Payable
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Other Accounts Payable of -$792.05 thousand for the 6-month period ending 2024-12-31, per its 10-Q filed 2025-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2025-02-13
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for the quarter ending 2024-12-31 was -$1.01M.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for the quarter ending 2024-09-30 was $221.34K, a 81.80% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for the quarter ending 2024-06-30 was -$151.67K, a 114.83% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for the quarter ending 2024-03-31 was $149.29K, a 50.21% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for fiscal 2024 was -$632.95K, a 849.04% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for fiscal 2023 was $84.50K, a 66.99% decline from fiscal 2022.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for fiscal 2022 was $255.98K, a 67.31% decline from fiscal 2021.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable for fiscal 2021 was $782.97K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$792.05K 10-Q · filed 2025-02-13 | -$943.72K derived: sum of 3 quarters · filed 2025-02-13 | -$794.43K derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-09-30 | $221.34K 10-Q · filed 2024-11-07 | $69.67K derived: sum of 2 quarters · filed 2024-11-07 | $218.96K derived: sum of 3 quarters · filed 2024-11-07 | -$1.63M derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-06-30 | -$151.67K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$2.38K derived: sum of 2 quarters · filed 2024-09-18 | -$1.85M derived: sum of 3 quarters · filed 2025-02-13 | -$632.95K 10-K · filed 2024-09-18 |
| 2024-03-31 | $149.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | -$1.70M derived: sum of 2 quarters · filed 2025-02-13 | -$481.28K 10-Q · filed 2024-05-08 | $541.18K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-12-31 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$630.57K 10-Q · filed 2025-02-13 | $391.89K derived: sum of 3 quarters · filed 2025-02-13 | $691.74K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $1.22M 10-Q · filed 2024-11-07 | $2.24M derived: sum of 2 quarters · filed 2024-11-07 | $2.54M derived: sum of 3 quarters · filed 2024-11-07 | $1.31M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $1.32M derived: sum of 2 quarters · filed 2024-09-18 | $97.80K derived: sum of 3 quarters · filed 2024-09-18 | $84.50K 10-K · filed 2024-09-18 |
| 2023-03-31 | $299.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | -$924.66K derived: sum of 2 quarters · filed 2024-05-08 | -$937.96K 10-Q · filed 2024-05-08 | -$167.09K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$1.24M 10-Q · filed 2024-02-09 | -$466.93K derived: sum of 3 quarters · filed 2024-02-09 | $10.52K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-09-30 | -$13.30K 10-Q · filed 2023-11-08 | $757.58K derived: sum of 2 quarters · filed 2023-11-08 | $1.24M derived: sum of 3 quarters · filed 2023-11-08 | $878.25K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $770.87K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $1.25M derived: sum of 2 quarters · filed 2023-08-23 | $891.55K derived: sum of 3 quarters · filed 2023-08-23 | $255.98K 10-K · filed 2023-08-23 |
| 2022-03-31 | $477.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $120.67K derived: sum of 2 quarters · filed 2023-05-11 | -$514.90K 10-Q · filed 2023-05-11 | -$412.84K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$356.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$992.35K 10-Q · filed 2023-02-14 | -$890.29K derived: sum of 3 quarters · filed 2023-02-14 | -$156.73K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$635.57K 10-Q · filed 2022-11-14 | -$533.52K derived: sum of 2 quarters · filed 2022-11-14 | $200.05K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $102.05K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $835.62K derived: sum of 2 quarters · filed 2022-09-22 | $782.97K 10-K · filed 2022-09-22 | |
| 2021-03-31 | $733.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $680.92K 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | -$52.64K 10-Q · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |